Synthesis of Quinazolines as Tyrosine Kinase Inhibitors

被引：21

作者：

Srivastava, Sanjay K. ^{[1
]}

Kumar, Vivek ^{[1
]}

Agarwal, Shiv K. ^{[1
]}

Mukherjee, Rama ^{[1
]}

Burman, Anand C. ^{[1
]}

机构：

[1] Dabur Res Fdn, Ghaziabad 201010, UP, India

来源：

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY | 2009年 / 9卷 / 03期

关键词：

GROWTH-FACTOR RECEPTOR; ATP-BINDING-SITE; IRREVERSIBLE INHIBITORS; SELECTIVE INHIBITORS; LAVENDUSTIN-A; PDGF RECEPTOR; POTENT; DERIVATIVES; 4-ANILINOQUINAZOLINES; PHOSPHORYLATION;

D O I：

10.2174/1871520610909030246

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In the present review, the discovery and development of quinazoline as tyrosine kinase inhibitors has been described. The synthesis of most potent quinazoline inhibitors of EGFR, VEGFR and PDGRF has been discussed. Structure activity relationship for quinazoline as tyrosine kinase inhibitors has been established. It was found that C-4, C-6 and C-7 positions in quinazoline are appropriate sites for designing new tyrosine kinase inhibitors. This review should help the medicinal chemist in designing more effective tyrosine kinase inhibitors.

引用

页码：246 / 275

页数：30

共 50 条

[41] Synthesis and in vitro anticancer evaluation of some fused indazoles, quinazolines and quinolines as potential EGFR inhibitors
Abdelsalam, Esraa A.
Zaghary, Wafaa A.
Amin, Kamilia M.
Abou Taleb, Nageh A.
Mekawey, Amal A., I
Eldehna, Wagdy M.
Abdel-Aziz, Hatem A.
Hammad, Sherif F.
BIOORGANIC CHEMISTRY, 2019, 89
[42] Role of Tyrosine Kinases and their Inhibitors in Cancer Therapy: A Comprehensive Review
Kumar, Vanktesh
Kaur, Navjot
Sahu, Sanjeev
Sharma, Vikas
Kumar, Deepak
Sharma, Ajit
Wadhwa, Pankaj
CURRENT MEDICINAL CHEMISTRY, 2023, 30 (13) : 1464 - 1481
[43] Redundant kinase activation and resistance of EGFR-tyrosine kinase inhibitors
Luo, Min
Fu, Li-Wu
AMERICAN JOURNAL OF CANCER RESEARCH, 2014, 4 (06): : 608 - 628
[44] Activity-based kinase profiling of approved tyrosine kinase inhibitors
Kitagawa, Daisuke
Yokota, Koichi
Gouda, Masaki
Narumi, Yugo
Ohmoto, Hiroshi
Nishiwaki, Eiji
Akita, Kensaku
Kirii, Yasuyuki
GENES TO CELLS, 2013, 18 (02) : 110 - 122
[45] SYNTHESIS OF SUBSTITUTED QUINAZOLINES: APPLICATION TO THE SYNTHESIS OF VERUBULIN
Lockman, Jeffrey W.
Klimova, Yevgeniya
Anderson, Mark B.
Willardsen, J. Adam
SYNTHETIC COMMUNICATIONS, 2012, 42 (12) : 1715 - 1723
[46] Synthesis and Biological Activity of 3,9-Diazatetraasteranes as Novel EGFR Tyrosine Kinase Inhibitors
Mao, Li
Tian, Nana
Wei, Chaochun
Wang, Hongjun
Yan, Hong
RUSSIAN JOURNAL OF GENERAL CHEMISTRY, 2022, 92 (03) : 446 - 456
[47] Design and Synthesis of Vandetanib Derivatives Containing Nitroimidazole Groups as Tyrosine Kinase Inhibitors in Normoxia and Hypoxia
Wei, Huiqiang
Li, Deguan
Yang, Xiangbo
Shang, Haihua
Fan, Saijun
Li, Yiliang
Song, Dan
MOLECULES, 2016, 21 (12)
[48] Targeting non-small cell lung cancer with small-molecule EGFR tyrosine kinase inhibitors
Singh, Mahaveer
Jadhav, Hemant R.
DRUG DISCOVERY TODAY, 2018, 23 (03) : 745 - 753
[49] Development of Specific, Irreversible Inhibitors for a Receptor Tyrosine Kinase EphB3
Kung, Alvin
Chen, Ying-Chu
Schimpl, Marianne
Ni, Feng
Zhu, Jianfa
Turner, Maurice
Molina, Henrik
Overman, Ross
Zhang, Chao
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2016, 138 (33) : 10554 - 10560
[50] Metal-Tyrosine Kinase Inhibitors: Targeted metal-drug conjugates
Beirne, Darren F.
Dalla Via, Martina
Velasco-Torrijos, Trinidad
Montagner, Diego
COORDINATION CHEMISTRY REVIEWS, 2022, 469

← 1 2 3 4 5 →